These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28859612)
21. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma. Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830 [TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403 [TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659 [TBL] [Abstract][Full Text] [Related]
24. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer. Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599 [TBL] [Abstract][Full Text] [Related]
25. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers. Yan M; Rayoo M; Takano EA; ; Fox SB Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651 [TBL] [Abstract][Full Text] [Related]
26. Cloning, characterisation, and expression of three oestrogen receptors (ERalpha, ERbeta1 and ERbeta2) in the European sea bass, Dicentrarchus labrax. Halm S; Martínez-Rodríguez G; Rodríguez L; Prat F; Mylonas CC; Carrillo M; Zanuy S Mol Cell Endocrinol; 2004 Aug; 223(1-2):63-75. PubMed ID: 15279912 [TBL] [Abstract][Full Text] [Related]
28. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193 [TBL] [Abstract][Full Text] [Related]
29. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy. Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554 [TBL] [Abstract][Full Text] [Related]
30. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer. Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588 [TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111 [TBL] [Abstract][Full Text] [Related]
32. Cloning, expression and functional characterization on vitellogenesis of estrogen receptors in Scatophagus argus. Cui XF; Zhao Y; Chen HP; Deng SP; Jiang DN; Wu TL; Zhu CH; Li GL Gen Comp Endocrinol; 2017 May; 246():37-45. PubMed ID: 28322764 [TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention. Poola I; Fuqua SA; De Witty RL; Abraham J; Marshallack JJ; Liu A Clin Cancer Res; 2005 Oct; 11(20):7579-85. PubMed ID: 16243834 [TBL] [Abstract][Full Text] [Related]
34. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer. Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366 [TBL] [Abstract][Full Text] [Related]
35. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091 [TBL] [Abstract][Full Text] [Related]
36. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. Mandusić V; Nikolić-Vukosavljević D; Tanić N; Kanjer K; Neskovic-Konstantinović Z; Celeketić D; Dimitrijević B J Cancer Res Clin Oncol; 2007 Aug; 133(8):571-9. PubMed ID: 17457609 [TBL] [Abstract][Full Text] [Related]
37. The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. Palmieri C; Saji S; Sakaguchi H; Cheng G; Sunters A; O'Hare MJ; Warner M; Gustafsson JA; Coombes RC; Lam EW J Mol Endocrinol; 2004 Aug; 33(1):35-50. PubMed ID: 15291741 [TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124 [TBL] [Abstract][Full Text] [Related]